Information Disclosure Statement (IDS) is a crucial component of U.S. patent prosecution. It serves as a formal mechanism through which inventors, applicants, and their legal representatives all known prior art relevant to patentability during prosecution, up to patent issuance (37 C.F.R. §§ 1.56, 1.97). This is done through an Information Disclosure Statement (IDS) submitted to the USPTO. Prior art includes both patent documents (e.g., published applications, issued patents) and non-patent literature (e.g., journal articles, theses, product brochures, presentations) that may impact the novelty or obviousness of the claimed invention.

Read Also: What is IDS Management? Step-by-Step Guide

Documents to be Submitted

The documents that come to the knowledge of the inventor/applicant, or attorney/agent representing the applicant

• Published applications or issued patents identified after the U.S. application is filed.
• References cited in office actions during PCT or foreign prosecution of the same or related applications.
• References listed in the International Search Report (ISR).
• References from related PCT or foreign counterpart applications filed later, submitted via supplemental IDS.

When to file the IDS?

• National applications (excluding CPAs): File within 3 months of filing or before the first Office action on the merits, whichever is later.
• International applications (national stage): File within 3 months of entering national stage (per 37 CFR 1.491) or before the first Office action on the merits, whichever is later.
• Continued examinations (RCEs and CPAs): File before the first Office action on the merits.
• International design applications: File within 3 months of publication under Hague Agreement Article 10(3) or before the first Office action on the merits, whichever is later.

Who Has a Duty of Disclosure?

Anyone substantively involved in preparation or prosecution of an application, including:

• Inventor(s)
• Attorneys,
• Agents,
• Paralegals
• In-house patent counsel

Disadvantage for not filing IDS

• The duty to disclose applies to all individuals involved in preparing or prosecuting a substantive patent application.
• It covers any material information relevant to the novelty or patentability of the invention.
• U.S. Patent Law mandates disclosure of such material prior art.
• Failure to disclose can lead to inequitable conduct, making the patent unenforceable due to intentional withholding of relevant information.

Best Practices Related to IDS Filings

• File the IDS with the initial application, followed by timely updates as needed.
• Avoid additional fees by submitting before the first Office action.
• Include references from foreign or related counterpart applications.
• Filing an IDS supports the applicant’s duty of candor failure to disclose may be deemed fraud.
• Disclosure of all material prior art is required under 37 C.F.R. § 1.56 to ensure patent enforceability.

Way Forward

Filing an IDS is a critical step in U.S. patent prosecution, ensuring compliance with the duty of disclosure under 37 C.F.R. §§ 1.56 and 1.97. Timely and complete submission of all relevant prior art both patent and non-patent helps avoid extra costs, protects against claims of inequitable conduct, and upholds the enforceability of the patent. Simply put, a well-managed IDS safeguards your patent and strengthens its legal standing.

About Effectual Services

At Effectual Services, we follow a rigorous and systematic approach to IDS preparation, ensuring that our clients receive a comprehensive and well-organized IDS package that includes ‘what’s new to cite’, ‘what’s already been cited’, ‘what’s not considered by Examiner’, so they can have the complete background and take decisions accordingly.

Follow Us: Linkedin, Twitter